These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Role of digital artery adrenoceptors in Raynaud's disease. Cooke JP; Creager SJ; Scales KM; Ren C; Tsapatsaris NP; Beetham WP; Creager MA Vasc Med; 1997; 2(1):1-7. PubMed ID: 9546943 [TBL] [Abstract][Full Text] [Related]
24. Serum endothelin-1 concentrations and cold provocation in primary Raynaud's phenomenon. Zamora MR; O'Brien RF; Rutherford RB; Weil JV Lancet; 1990 Nov; 336(8724):1144-7. PubMed ID: 1978025 [TBL] [Abstract][Full Text] [Related]
25. Induced vasodilation as treatment for Raynaud's disease. Jobe JB; Sampson JB; Roberts DE; Beetham WP Ann Intern Med; 1982 Nov; 97(5):706-9. PubMed ID: 7137735 [TBL] [Abstract][Full Text] [Related]
26. The origin of Raynaud's phenomenon. Nielubowicz J; Zajaç S; Szamowska R; Adamski M J Cardiovasc Surg (Torino); 1978; 19(6):607-14. PubMed ID: 739033 [TBL] [Abstract][Full Text] [Related]
27. Relationship of age and body mass index to skin temperature and skin perfusion in primary Raynaud's phenomenon. Giurgea GA; Mlekusch W; Charwat-Resl S; Mueller M; Hammer A; Gschwandtner ME; Koppensteiner R; Schlager O Arthritis Rheumatol; 2015 Jan; 67(1):238-42. PubMed ID: 25330753 [TBL] [Abstract][Full Text] [Related]
28. The behavioral treatment of Raynaud's disease: a review. Rose GD; Carlson JG Biofeedback Self Regul; 1987 Dec; 12(4):257-72. PubMed ID: 3331296 [TBL] [Abstract][Full Text] [Related]
29. A multiclinic, placebo-controlled, double-blind study of prostaglandin E1 in Raynaud's syndrome. Mohrland JS; Porter JM; Smith EA; Belch J; Simms MH Ann Rheum Dis; 1985 Nov; 44(11):754-60. PubMed ID: 3904643 [TBL] [Abstract][Full Text] [Related]
31. Reproducibility of cold provocation in patients with Raynaud's phenomenon. Wigley FM; Malamet R; Wise RA J Rheumatol; 1987 Aug; 14(4):751-5. PubMed ID: 3668980 [TBL] [Abstract][Full Text] [Related]
32. Seasonal differences in finger skin temperature and microvascular blood flow in healthy men and women are exaggerated in women with primary Raynaud's phenomenon. Gardner-Medwin JM; Macdonald IA; Taylor JY; Riley PH; Powell RJ Br J Clin Pharmacol; 2001 Jul; 52(1):17-23. PubMed ID: 11453886 [TBL] [Abstract][Full Text] [Related]
33. Induction of vasospastic attacks despite digital nerve block in Raynaud's disease and phenomenon. Freedman RR; Mayes MD; Sabharwal SC Circulation; 1989 Oct; 80(4):859-62. PubMed ID: 2791249 [TBL] [Abstract][Full Text] [Related]
34. Effects of brief cold exposure on finger dexterity and sensibility in subjects with Raynaud's phenomenon. Delp HL; Newton RA Phys Ther; 1986 Apr; 66(4):503-7. PubMed ID: 3960975 [TBL] [Abstract][Full Text] [Related]
36. Apparent finger systolic pressures during cooling in patients with Raynaud's syndrome. Carter SA; Dean E; Kroeger EA Circulation; 1988 May; 77(5):988-96. PubMed ID: 3359596 [TBL] [Abstract][Full Text] [Related]
37. Digital artery calibre measurement--a new technique of assessing Raynaud's phenomenon. Singh S; de Trafford JC; Baskerville PA; Roberts VC Eur J Vasc Surg; 1991 Apr; 5(2):199-203. PubMed ID: 2037091 [TBL] [Abstract][Full Text] [Related]
38. The effects of tadalafil on cold-induced vasoconstriction in patients with Raynaud's phenomenon. Friedman EA; Harris PA; Wood AJ; Stein CM; Kurnik D Clin Pharmacol Ther; 2007 Apr; 81(4):503-9. PubMed ID: 17301734 [TBL] [Abstract][Full Text] [Related]
39. Fish-oil dietary supplementation in patients with Raynaud's phenomenon: a double-blind, controlled, prospective study. DiGiacomo RA; Kremer JM; Shah DM Am J Med; 1989 Feb; 86(2):158-64. PubMed ID: 2536517 [TBL] [Abstract][Full Text] [Related]
40. Behavioral treatment of Raynaud's phenomenon in scleroderma. Freedman RR; Ianni P; Wenig P J Behav Med; 1984 Dec; 7(4):343-53. PubMed ID: 6520866 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]